
|Videos|December 16, 2021
New Delivery Option for Ketamine
Author(s)Jeffrey Becker, MD
How can new formulations of ketamine impact patient care?
Advertisement
Jeffrey Becker, MD, discusses new formulations of ketamine for subcutaneous delivery and how ketamine works.
Dr Becker is cofounder and Chief Scientific Officer at Bexson Biomedical, Inc.
Newsletter
Receive trusted psychiatric news, expert analysis, and clinical insights — subscribe today to support your practice and your patients.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Psychiatric Times
1
Chatbot Privacy Is an Oxymoron: Assume Your Data Is Always At Risk
2
2025 Schizophrenia Insights: Ending the Year With Positive Data
3
Nature Nurtures: Evidence for Nature’s Impact on Mental Well-Being
4
Continuing Conversations in Lifestyle Psychiatry
5













